Multi-site Study of Rapid Diagnostic Syphilis Assays
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert E. Johnson, MD, MPH
Centers for Disease Control and Prevention
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Los Angeles Department of Health Services
Los Angeles, California, United States
- Fulton County Department of Health
Atlanta, Georgia, United States
- Chicago Department of Public Health
Chicago, Illinois, United States
- Bell Flower Clinic
Indianapolis, Indiana, United States
- New York City Department of Health
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2002
- Primary completion
- 31 Dec 2005
- Completion
- 31 Jul 2009
- Last update posted
- 7 Sept 2012
- Registered enrollment
- 1,000
- Registry id
- NCT00300534
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.